ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases.
A central role in infectious diseases research for over 35 years
Supporting research to prevent, understand and treat infectious diseases
ANRS MIE three majors levels of action
ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.
Patient associations, next generation of scientists, quality and ethical approach, open science
Our agency funds, coordinates, evaluates and facilitates research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases.
Learn more about the diseases and pathogens covered by our research
Information on the projects we fund
Our workgroups bring together researchers and representatives of civil society
Guiding and advising innovative project leaders
The agency supports a number of research platforms and networks to federate and help shape research in its field
National and international research platforms supported by the agency and designed for the scientific community
Clinical research networks and networks of young researchers
Access to data and biological collections from research promoted by the agency
The agency is a member of various networks and forges partnerships with national and international associations, organisations and initiatives
Partner sites, international global health research platforms, ad hoc partnerships
WHO, Ministry of Europe and Foreign Affairs, Global Health EDCTP3 Joint Undertaking, structuring networks
Strategic international projects and capacity-building programmes
Fighting epidemics: ANRS MIE leads WHO filovirus CORC
Collaboration with community stakeholders
Each year, the agency offers two calls for generic projects and calls for thematic projects. Some are jointly carried out with other research players
Agency's current, forthcoming and completed calls for proposals
Find out the list of calls for projects previously funded by the agency
Find out the Start programme, here to support and guide the next generation of scientific researchers
ANRS MIE is a key player in crisis preparedness and response
Facilitation and watch procedure for responding to emerging or re-emerging epidemics
A Level 1 Outbreak Response Unit for MERS-CoV, opened on 11 December 2025
This Outbreak Response Unit for several diseases is active since March 2025
Opened since January 2025 and still active since the detection of one new case in French Guiana in January 2026
A level 1 Outbreak Response Unit since December 2023, monitoring new cases in Mayotte and La Réunion
ANRS MIE continues to follow H5N1 closely since June 2024
Submit a project
Here you can find all the latest news and events relating to our areas of research.
Share:
Trier par
The coordinated action 42 “Hepatitis viruses” organized the annual meeting of the Réseau National Hépatites virales on March 11 and 12, 2025 at the Institut Pasteur in Paris.
At its plenary meeting on March 11 and 12, 2025 at the Institut Pasteur, the ANRS MIE Coordinated Action “Fundamental and translational research on viral hepatitis”, in collaboration with the Société française de virologie, awarded its thesis prizes for work completed in 2024.
CROI, the international Conference on Retroviruses and Opportunistic Infections, will be held from March 9 to 12 in San Francisco. Around 20 projects supported by ANRS MIE have been accepted.
In partnership with ANRS MIE, AFRAVIH offers a new ‘Training course in clinical health research’ in 2025.
In an article relayed by ‘Le Monde’ on 15 February 2025, a group of researchers, doctors, representatives of associations and the ANRS Emerging Infectious Diseases are concerned about the first measures taken by the Trump administration, and point out that international cooperation is vital if...
Interview with Dr Guillaume Conort, Department of General Medicine, University of Bordeaux
A major initiative to strengthen pandemic preparedness through clinical trial networks
03 February 2025, online and at Espace Saint Martin, Paris
